M&T Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
RI
FCM
M&T Bank's RARE Position: Q2 2026 in Review
M&T Bank reduced its Ultragenyx Pharmaceutical (RARE) stake by 41% in Q2 2026, selling an estimated $123K and leaving 7,000 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.
M&T Bank first reported a position in RARE in Q2 2015 and has held it in 12 quarters since. The position peaked at $388K in Q3 2024. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.
- M&T Bank held 7,000 shares of Ultragenyx Pharmaceutical worth $234K as of Q2 2026.
- M&T Bank sold 4,952 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $123K.
- Ultragenyx Pharmaceutical made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1580 holding.
- M&T Bank first reported a position in Ultragenyx Pharmaceutical in Q2 2015 and has held it in 12 quarters since.
- M&T Bank's Ultragenyx Pharmaceutical position peaked at $388K in Q3 2024.
- 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.
Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.